Test Compendium
Test Compendium is your definitive resource for detailed information on a wide array of diagnostic tests. Each entry in our compendium is meticulously cataloged to aid healthcare providers in selecting and interpreting the right tests for their patients.
Displaying 176 - 200 of 352
HBME-1
Immunohistochemistry (IHC)HBME-1 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes HBME1 IHC Disease Thyroid carcinomaThe monoclonal antibody against HBME-1 targets an unknown antigen of mesothelial cells
HepPar 1
Immunohistochemistry (IHC)HepPar 1 Alternative Name Anti-Hepatocyte Specific Antigen Methodology Immunohistochemistry (IHC) Test Description Probes/Genes HEPPAR1 IHC Disease Hepatocellular carcinoma, may be biomarker for early
HHV8
Immunohistochemistry (IHC)HHV8 Alternative Name Human Herpesvirus, Type 8 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes HHV8 IHC Disease Kaposi sarcomaHHV8 demonstration by Immunostain
HMB45
Immunohistochemistry (IHC)HMB45 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes HMB 45 IHC Disease Melanoma, ruling out diagnosis of perivascular epithelioid cell tumors (angiomyolipoma, lymphangioleiomyomatoisis,
HNF-1-beta
Immunohistochemistry (IHC)HNF-1-beta Alternative Name Hepatocyte Nuclear Factor 1 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes HNF-1-B IHC Disease Ovarian clear cell carcinoma and endometrial clear cell
HSV I
Immunohistochemistry (IHC)HSV I Alternative Name Herpes Simplex 1 Antigen Methodology Immunohistochemistry (IHC) Test Description Probes/Genes HSVI IHC Disease Identification of herpes simplex virus I infectionImmunohistochemistry
HSV II
Immunohistochemistry (IHC)HSV II Alternative Name Herpes Simplex 2 Antigen Methodology Immunohistochemistry (IHC) Test Description Probes/Genes HSVII IHC Disease Identification of herpes simplex virus 2 infectionImmunohistochemistry
IgA
Immunohistochemistry (IHC)IgA Alternative Name Immunoglobulin A Methodology Immunohistochemistry (IHC) Test Description Probes/Genes IGA IHC Disease Aiding in the classification of lymphomas and multiple myelomaIgA antibody reacts
IgD
Immunohistochemistry (IHC)IgD Alternative Name Immunoglobulin D Methodology Immunohistochemistry (IHC) Test Description Probes/Genes IGD IHC Disease Aiding in the classification of lymphomas (marginal zone, mantle zone) and multiple
IgG
Immunohistochemistry (IHC)IgG Alternative Name Immunoglobulin G Methodology Immunohistochemistry (IHC) Test Description Probes/Genes IGG IHC Disease Classification of lymphomas and multiple myelomaIgG antibody reacts with surface
IgG4
Immunohistochemistry (IHC)IgG4 Alternative Name Immunoglobulin G4 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes IGG4 IHC Disease IgG4 related sclerosing diseasesIdentification of IgG4-positive plasma cells
IgM
Immunohistochemistry (IHC)IgM Alternative Name Immunoglobulin M Methodology Immunohistochemistry (IHC) Test Description Probes/Genes IGM IHC Disease Aiding in the classification of lymphomas and multiple myelomaIgM antibody reacts
Inhibin
Immunohistochemistry (IHC)Inhibin Methodology Immunohistochemistry (IHC) Test Description Probes/Genes INHIBI IHC Disease Sex-cord stromal tumors, including Sertoli cell tumors, Leydig cell tumors , adrenocortical tumors, placental
Iron
Special StainsIron Alternative Name Prussian Blue Iron, Ferric Iron Methodology Special Stains Test Description Probes/Genes FE SS Disease Hemochromatosis, hemosiderosis and chromophobe renal cell carcinomaThe iron
Lysozyme
Immunohistochemistry (IHC)Lysozyme Methodology Immunohistochemistry (IHC) Test Description Probes/Genes LYSO IHC Disease Acute myelomonocytic leukemia (M4), acute monocytic leukemia (M5)Also called muramidase Histiocytic enzyme
Kappa (IHC)
Immunohistochemistry (IHC)Kappa (IHC) Alternative Name Kappa Light Chain by IHC Methodology Immunohistochemistry (IHC) Test Description Probes/Genes KAPPA IHC Disease Monoclonality in malignant plasmacytic or lymphoid populations,
Ki-67
Immunohistochemistry (IHC)Ki-67 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes KI-67 IP Disease Used to help differentiate between benign versus malignant and increasingly used to grade various tumors (e.g.
Ki-67 (MIB-1)
Immunohistochemistry (IHC)Ki-67 (MIB-1) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes MIB1 IHC Disease Used to help differentiate between benign versus malignant and increasingly used to grade various tumors
KRAS by IHC
Immunohistochemistry (IHC)KRAS by IHC Methodology Immunohistochemistry (IHC) Test Description Probes/Genes KRAS IHC Disease Pancreatic and colorectal cancer, Non-small cell lung cancer & ductal carcinoma of the pancreas, cardiofaciocutaneous
Lambda (IHC)
Immunohistochemistry (IHC)Lambda (IHC) Alternative Name Lambda Light Chain IgG Methodology Immunohistochemistry (IHC) Test Description Probes/Genes LAMBDA IHC Disease Restricted expression of either kappa or lambda suggests monoclonality
Mammaglobin
Immunohistochemistry (IHC)Mammaglobin Methodology Immunohistochemistry (IHC) Test Description Probes/Genes Mamma IHC Disease Breast cancersBelongs to the family of small epithelial secretory proteins (secretoglobins) of the uteroglobin/Clara
Melan A (Mart-1)
Immunohistochemistry (IHC)Melan A (Mart-1) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes MART1 IHC Disease Melanocytic tumors, and metastatic melanomasMelanocyte specific cytoplasmic protein involved in the
MiTF-1
Immunohistochemistry (IHC)MiTF-1 Alternative Name Microphthalmia Transcription Factor Methodology Immunohistochemistry (IHC) Test Description Probes/Genes MiTF IHC Disease Marker of melanocytic differentiation or melanin synthesis
MLH-1
Immunohistochemistry (IHC)MLH-1 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes MSI Disease Lynch SyndromeA mismatch repair protein alongside MSH2, MSH6 and PMS2. Tumor screening test for all newly diagnosed
MOC31
Immunohistochemistry (IHC)MOC31 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes MOC31 IHC Disease Cholangiocarcinoma, liver metastases, lung adenocarcinoma, invasive ductal carcinoma of the breast, and invasive
